These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15792283)

  • 1. The smoker's paradox and the real risk of smoking.
    Kunz F; Pechlaner C; Hörtnagl H; Pfister R
    Eur J Epidemiol; 2005; 20(2):161-7. PubMed ID: 15792283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoker's Paradox in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Gupta T; Kolte D; Khera S; Harikrishnan P; Mujib M; Aronow WS; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27107131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in left ventricular systolic function in patients with ST elevation myocardial infarction: Evidence for smoker's paradox or pseudo-paradox?
    Acar B; Ozeke O; Unal S; Karakurt M; Kara M; Kirbas O; Sen F; Korkmaz A; Aras D; Aydogdu S
    Indian Heart J; 2016; 68(6):816-820. PubMed ID: 27931553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a 'smoker's paradox' in field triaged ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Allahwala UK; Murphy JC; Nelson GI; Bhindi R
    Cardiovasc Revasc Med; 2013; 14(4):213-7. PubMed ID: 23856073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The etiology of 'smoker's paradox' in acute myocardial infarction with special emphasis on the association with inflammation.
    Katayama T; Iwasaki Y; Sakoda N; Yoshioka M
    Int Heart J; 2008 Jan; 49(1):13-24. PubMed ID: 18360061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker's paradox.
    Plakogiannis FA; Weidmann J; Fraser B; Kwong J; Asi D; Kumar P; Baldock M; Naamo J; Baluja R; Catanzariti R; Yeung S; Pont L; Williams K; De Rubis G; Dua K; Bukhari NI
    Pathol Res Pract; 2024 May; 257():155290. PubMed ID: 38640781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited.
    Symons R; Masci PG; Francone M; Claus P; Barison A; Carbone I; Agati L; Galea N; Janssens S; Bogaert J
    Eur Heart J; 2016 Sep; 37(36):2756-2764. PubMed ID: 26804461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of smoking on survival after myocardial infarction - smoker's paradox in Hungary?].
    El-Meouch NM; Ferenci T; Jánosi A
    Orv Hetil; 2018 Apr; 159(14):557-565. PubMed ID: 29611752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited.
    Weisz G; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey TD; Rutherford BD; Mehran R; Aymong E; Lansky A; Grines CL; Stone GW
    Am Heart J; 2005 Aug; 150(2):358-64. PubMed ID: 16086943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
    Barbash GI; Reiner J; White HD; Wilcox RG; Armstrong PW; Sadowski Z; Morris D; Aylward P; Woodlief LH; Topol EJ
    J Am Coll Cardiol; 1995 Nov; 26(5):1222-9. PubMed ID: 7594035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Smoker's paradox' in young patients with acute myocardial infarction.
    Chen KY; Rha SW; Li YJ; Jin Z; Minami Y; Park JY; Poddar KL; Ramasamy S; Wang L; Li GP; Choi CU; Oh DJ; Jeong MH;
    Clin Exp Pharmacol Physiol; 2012 Jul; 39(7):630-5. PubMed ID: 22551379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can divergent plasmin-antiplasmin-carbon monoxide interactions in young, healthy tobacco smokers explain the 'smoker's paradox'?
    Nielsen VG; Hafner DT; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):381-5. PubMed ID: 23429256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "smoker's paradox" in patients with acute coronary syndrome: a systematic review.
    Aune E; Røislien J; Mathisen M; Thelle DS; Otterstad JE
    BMC Med; 2011 Aug; 9():97. PubMed ID: 21861870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of smoking on mortality after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: a retrospective cohort outcome study at 3 years.
    Steele L; Palmer J; Lloyd A; Fotheringham J; Iqbal J; Grech ED
    J Thromb Thrombolysis; 2019 May; 47(4):520-526. PubMed ID: 30666553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To Be Or Not to Be: the "Smoker's Paradox" - An in-Vitro Study.
    Wittmann F; Türkcan A; Baranyi U; Eichmair E; Laufer G; Bernhard D; Messner B
    Cell Physiol Biochem; 2018; 48(4):1638-1651. PubMed ID: 30077999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of smoking with myocardial injury and clinical outcome in patients undergoing mechanical reperfusion for ST-elevation myocardial infarction.
    Reinstadler SJ; Eitel C; Fuernau G; de Waha S; Desch S; Mende M; Metzler B; Schuler G; Thiele H; Eitel I
    Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):39-45. PubMed ID: 26976354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between salivary cotinine and cardiovascular biomarkers among nonsmokers and current smokers: cross-sectional study of 10,081 participants.
    Lu L; Mackay DF; Newby DE; Pell JP
    Eur J Vasc Endovasc Surg; 2014 Dec; 48(6):703-10. PubMed ID: 25454789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thienopyridine efficacy and cigarette smoking status.
    Bliden KP; Baker BA; Nolin TD; Jeong YH; Bailey WL; Tantry US; Gurbel PA
    Am Heart J; 2013 May; 165(5):693-703. PubMed ID: 23622905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of smoking on cardiac magnetic resonance infarct characteristics and clinical outcome in patients with non-ST-elevation myocardial infarction.
    Feistritzer HJ; Eitel I; Jobs A; de Waha-Thiele S; Stiermaier T; Abdel-Wahab M; Lurz P; Reinstadler SJ; Reindl M; Klug G; Metzler B; Desch S; Thiele H
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):1079-1087. PubMed ID: 30771036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Smoker's paradox" in patients with cardiogenic shock complicating myocardial infarction - A substudy of the IABP-SHOCK II-trial and registry.
    Saad M; Fuernau G; Desch S; Eitel I; Jung C; Pöss J; Schneider S; Schuler G; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2016 Nov; 222():775-779. PubMed ID: 27521557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.